Vitamin D deficiency. Vitamin D deficiency
Conditions
Interventions
Intervention 1: Intervention group: Routine anti-hypertensive drugs plus gelatin tablet vitamin D (Calciferol) based on Vitamin D serum level (50,000 U once a week oral in subjects with Vitamin D seru
Treatment - Drugs
Placebo
Intervention group: Routine anti-hypertensive drugs plus gelatin tablet vitamin D (Calciferol) based on Vitamin D serum level (50,000 U once a week oral in subjects with Vitamin D serum level less tha
Control group: Routine anti-hypertensive drugs plus gelatin tablet placebo once a week for 2 months.
Sponsors
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age of 18 to 75 years; systolic blood pressure equal to or greater than 140 mmHg or diastolic blood pressure equal to or greater than 90 mmHg in tow times; vitamin D deficiency. Exclusion criteria: Pregnancy; secondary hypertension; renal failure; a history of using vitamin D or calcium during the last three months; using Thiazide-type diuretics.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measuring systolic and diastolic blood pressure. Timepoint: before intervention and then monthly for 2 months. Method of measurement: in sitting position from the right hand using mercury sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measuring serum Calciferol. Timepoint: before intervention and then monthly for 2 months. Method of measurement: through laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Vida Sheikh
Farshchian Heart Hospital
Outcome results
None listed